COVID-19: Vaccines and Therapeutics
Recorded March 30, 2021
12-1 p.m. ET
The Food and Drug Administration launched a dashboard that will provide weekly updates on adverse events submitted to its adverse event reporting system for COVID-19 drugs and biological products authorized for emergency use.
President Biden March 11 signed into law the American Rescue Plan Act of 2021, a $1.9 trillion COVID-19 relief package, which includes a number of provisions that affect hospitals and health systems. A summary of provisions affecting hospitals and health systems follows.
Moderna announced the administration of first COVID-19 vaccine doses to participants between the ages of 6 months and 12 years old as part of a phase 2/3 clinical trial.
Medicare will nearly double what it pays to administer COVID-19 vaccines to about $40 per dose to better reflect the costs involved and help providers vaccinate more Americans, the Centers for Medicare & Medicaid Services announced today.
As urged by the AHA, the Centers for Medicare & Medicaid Services (CMS) today announced it is increasing the Medicare payment rates for COVID-19 vaccine administration.
President Biden directed states, tribes and territories to make all adults eligible for COVID-19 vaccination by May 1.
President Biden, citing the need for maximum flexibility in the nation’s vaccination program, announced a deal for the U.S. government to purchase an additional 100 million doses of Johnson & Johnson’s single-shot COVID-19 vaccine.
With the emergency use authorization for a third COVID-19 vaccine, progress is being made in efforts to vaccinate the public. Still, challenges remain, particularly with communication around supplies and eligibility.
FEMA has established the Civil Rights Advisory Group as part of the agency’s commitment to the COVID-19 vaccination mission amid the ongoing battle against the pandemic.